FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
Aegis Capital cuts its price target on Auxilium Pharmaceuticals (Nasdaq: AUXL) from $37 to $34 and affirms its Buy rating following Q2 results issued... More